ISPOR - Cost-Effectiveness Analysis of Secukinumab Compared To Current Biologics Sequences For The Treatment of Moderate To Severe Plaque Psoriasis In France

Full Text

Cost-Effectiveness Analysis of Secukinumab Compared To Current Biologics Sequences For The Treatment of Moderate To Severe Plaque Psoriasis In France

Abstract

Authors

E Duteil C Cariou A Schmidt K Benjamin J Duco

Back to Volume 19, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now